Skip to contentT
TuHURA Biosciences, Inc.
T
HURATuHURA Biosciences, Inc. Q1 2024 · 10-Q
Revenue$0.00$0.00no prior Q1 2023 on file Net Income-$4.84M-$4.84Mno prior Q1 2023 on file EPS Diluted-$0.40-$0.40no prior Q1 2023 on file Operating Cash Flow-$3,834,245— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end